Effect of CYP2D6 Genetic Polymorphism and Metabolic Inhibition on the Pharmacokinetics and QTc Intervals Ofter Single Oral Administration of Flecainide in Healthy Subjects

Lim Kyoung-Soo (Department of Pharmacology and Clinical Pharmacology Unit, Seoul National University College of Medicine and Hospital) ;
Kim Jung-Ryul (Department of Pharmacology and Clinical Pharmacology Unit, Seoul National University College of Medicine and Hospital) ;
Kim Jae-Woo (Department of Pharmacology and Clinical Pharmacology Unit, Seoul National University College of Medicine and Hospital) ;
Kim Bo-Hyung (Department of Pharmacology and Clinical Pharmacology Unit, Seoul National University College of Medicine and Hospital) ;
Jeon Ji-Young (Department of Pharmacology and Clinical Pharmacology Unit, Seoul National University College of Medicine and Hospital) ;
Chung On-Hee (Department of Pharmacology and Clinical Pharmacology Unit, Seoul National University College of Medicine and Hospital) ;
Tae Yu-Mi (Department of Pharmacology and Clinical Pharmacology Unit, Seoul National University College of Medicine and Hospital) ;
Cho Joo-Youn (Department of Pharmacology and Clinical Pharmacology Unit, Seoul National University College of Medicine and Hospital) ;
Yu Kyung-Sang (Department of Pharmacology and Clinical Pharmacology Unit, Seoul National University College of Medicine and Hospital) ;
Jang In-Jin (Department of Pharmacology and Clinical Pharmacology Unit, Seoul National University College of Medicine and Hospital) ;
Shin Sang-Goo (Department of Pharmacology and Clinical Pharmacology Unit, Seoul National University College of Medicine and Hospital)